POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240343823A1
SERIAL NO

18432750

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present technology aims at providing a novel type of drug for treating a subject suffering from cancer. Specifically, the technology provides polypeptides comprising at least four immunoglobulin single variable domains (ISVDs), characterized in that one ISVD binds to TCR and at least two ISVDs bind to GPC3. The present technology also provides nucleic acids, vectors and compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABLYNX N VTECHNOLOGIEPARK 21 9052 ZWIJNAARDE BELGIUM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boutton, Carlo Wielsbeke, BE 56 373
Dombrecht, Evelyne Zwijnaarde, BE 2 0
Janssen, Daniel Mortsel, BE 6 26
Laukens, Bram Zwijnaarde, BE 5 0
Meoni, Paolo Zwijnaarde, BE 3 0
Pao, Lily Bridgewater, US 2 0
Pype, Jan Herne, BE 11 5
Schotte, Peter De Pinte, BE 28 132
Serruys, Benedikte Sint-Michiels, BE 2 0
Van, Hoorick Diane Zwijnaarde, BE 21 122
Vintem, Ana Paula Zwijnaarde, BE 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation